Paper
Activity of a novel carbapenem, doripenem, against anaerobic pathogens.
Published Apr 1, 2009 · E. Goldstein, D. Citron
Diagnostic microbiology and infectious disease
Q2 SJR score
19
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Doripenem is a novel carbapenem with broad-spectrum activity against anaerobic bacteria, potentially reducing disease rates and requiring less antibiotic treatment.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···